文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

NO 在 COVID-19 中的作用及潜在治疗策略。

The role of NO in COVID-19 and potential therapeutic strategies.

机构信息

National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Wuhan, Hubei, China; Department of Biomedicine and Biopharmacology, Hubei University of Technology, Wuhan, Hubei, China.

National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Wuhan, Hubei, China; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Free Radic Biol Med. 2021 Feb 1;163:153-162. doi: 10.1016/j.freeradbiomed.2020.12.008. Epub 2020 Dec 22.

DOI:10.1016/j.freeradbiomed.2020.12.008
PMID:33347987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7754882/
Abstract

Nitric oxide (NO) is a free radical playing an important pathophysiological role in cardiovascular and immune systems. Recent studies reported that NO levels were significantly lower in patients with COVID-19, which was suggested to be closely related to vascular dysfunction and immune inflammation among them. In this review, we examine the potential role of NO during SARS-CoV-2 infection from the perspective of the unique physical, chemical and biological properties and potential mechanisms of NO in COVID-19, as well as possible therapeutic strategies using inhaled NO. We also discuss the limits of NO treatment, and the future application of this approach in prevention and therapy of COVID-19.

摘要

一氧化氮（NO）是一种自由基，在心血管和免疫系统中发挥着重要的病理生理作用。最近的研究报告指出，COVID-19 患者的 NO 水平显著降低，这与其中的血管功能障碍和免疫炎症密切相关。在这篇综述中，我们从 NO 的独特物理、化学和生物学特性以及 COVID-19 中 NO 的潜在机制的角度，探讨了 NO 在 SARS-CoV-2 感染过程中的潜在作用，以及使用吸入一氧化氮的可能治疗策略。我们还讨论了 NO 治疗的局限性，以及这种方法在 COVID-19 预防和治疗中的未来应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/6c2445cd633c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/2afbf8a9aa5a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/0224591a83a3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/c0e17e926e83/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/6c2445cd633c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/2afbf8a9aa5a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/0224591a83a3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/c0e17e926e83/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a007/7754882/6c2445cd633c/gr3_lrg.jpg

相似文献

[1]
The role of NO in COVID-19 and potential therapeutic strategies.

Free Radic Biol Med. 2021-2-1

[2]
Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).

Carbohydr Res. 2021-7

[3]
The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.

Int J Mol Sci. 2023-12-5

[4]
Comprehensive Landscape of Heparin Therapy for COVID-19.

Carbohydr Polym. 2021-2-15

[5]
Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.

Basic Clin Pharmacol Toxicol. 2022-2

[6]
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.

Clin Med (Lond). 2020-8-30

[7]
Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Inflammopharmacology. 2021-4

[8]
Nitric Oxide to Fight Viral Infections.

Adv Sci (Weinh). 2021-4

[9]
Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project.

Andrology. 2021-1

[10]
Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Protein J. 2021-12

引用本文的文献

[1]
Nitric Oxide Therapeutics: New Hopes for More Effective Tuberculosis Treatment Combine with Targeted and Controlled Nanotechnology.

Int J Nanomedicine. 2025-7-19

[2]
Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial.

BMC Cardiovasc Disord. 2025-7-18

[3]
Antiviral Intervention of COVID-19: Linkage of Disease Severity with Genetic Markers FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760).

Viruses. 2025-5-30

[4]
Cytokines from Macrophages Activated by Spike S1 of SARS-CoV-2 Cause eNOS/Arginase Imbalance in Endothelial Cells.

Int J Mol Sci. 2025-6-19

[5]
Insights on the Anti-Inflammatory and Anti-Melanogenic Effects of 2'-Hydroxy-2,6'-dimethoxychalcone in RAW 264.7 and B16F10 Cells.

Curr Issues Mol Biol. 2025-1-29

[6]
Immunometabolic Effect of Nitric Oxide on Human Macrophages Challenged With the SARS-CoV2-Induced Cytokine Storm. A Fluxomic Approach.

Adv Healthc Mater. 2025-1

[7]
Potential Mechanisms for Organoprotective Effects of Exogenous Nitric Oxide in an Experimental Study.

Biomedicines. 2024-3-23

[8]
Evaluation of NO-Sartans against SARS-CoV-2.

Curr Drug Discov Technol. 2024

[9]
The Association Between Tobacco Use and Risk of COVID-19 Infection and Clinical Outcomes in Sweden: A Population-Based Study.

Int J Public Health. 2023

[10]
Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases?

Front Microbiol. 2023-10-2

本文引用的文献

[1]
COVID-19 and cardiovascular comorbidities: An update.

Rev Port Cardiol (Engl Ed). 2020-8

[2]
Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation.

Crit Care Explor. 2020-8-24

[3]
High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19).

Obstet Gynecol. 2020-12

[4]
Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.

Eur J Pharmacol. 2020-8-20

[5]
Inhaled nitric oxide in mechanically ventilated patients with COVID-19.

J Crit Care. 2020-12

[6]
Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia.

Crit Care. 2020-8-17

[7]
Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.

Inflamm Res. 2020-8-7

[8]
Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19.

Nitric Oxide. 2020-7-15

[9]
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.

Blood. 2020-9-10

[10]
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.

Clin Appl Thromb Hemost. 2020

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索